Ultraviolet Blood Irradiation (UBI or UVBI) was first introduced in the 1930s to combat the polio virus, and was ignored in later decades of medical use. With today’s increasing bacterial resistance to antibiotics and paucity of effective anti-viral agents UBI has again emerged.
UBI is intravenously applied by irradiating blood with a controlled amount of ultraviolet energy in the accepted therapeutic UV band. This produces a rapid detoxifying effect with the subsidence of toxic symptoms. No harmful effects have been observed in UBI therapy in thousands of cases of viral infections, hepatitis, bacterial infections and many other diseases.
Clinical indications include:
- Viral infections: hepatitis, herpes, mononucleosis, etc
- Bacterial infections
- Wound infections
- Furunculosis, carbunculosis
- Inflammatory process: thrombophlebitis, fibrositis, cholecystitis, pancreatitis
- Diseases due to inadequate peripheral circulation
- Varicose or diabetic ulcers
- Peripheral atherosclerosis
- Some types of gangrene
- Vascular headache
- Non-healing wounds and delayed union fractures
- Rheumatoid arthritis and other autoimmune diseases
UBI represents a safe, non-toxic, low cost and drug-free method of treating most blood-borne infections and it offers hope to those who suffer from viral or bacterial infections that are currently untreatable. It directly kills infectious agents of many types, stimulates the immune system, helps the red blood cells ‘hold’ more oxygen (thus oxygenating the blood), improves circulation, decreases inflammation, and assists in the breakdown of toxins for their subsequent elimination.